You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Ethics and Professionalism – Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review

Financial payments from the drug industry to physicians are common in the United States. This systematic review of 36 studies examines associations between industry payments and physician prescribing.

Use this article to:

  • Ask yourself if you're surprised by the findings of this review.
  • Do you think that physicians should inform patients when prescribing a drug marketed by an entity that the physician has a financial relationship with?
  • Should health care organizations allow clinicians to have industry relationships?

Annals of Internal Medicine is the premier internal medicine academic journal published by the American College of Physicians (ACP). It is one of the most widely cited and influential specialty medical journals in the world.

Back to the May 2021 issue of ACP IMpact